Evidence map›Paper›PMID 41206550›Full record

Trial reportClinical infectious diseases : an official publication of the Infectious Diseases Society of America2025

Effects of a Water, Sanitation, and Hygiene Program on Diarrhea, Cholera, and Child Growth in the Democratic Republic of the Congo: A Cluster-Randomized Controlled Trial of the Preventative Intervention for Cholera for 7 Days (PICHA7 WASHmobile) Mobile Health Program.

Christine Marie George, Presence Sanvura, Jean-Claude Bisimwa, Kelly Endres, Alves Namunesha, Willy Felicien, Blessing Muderhwa Banywesize, Camille Williams, Jamie Perin, David A Sack and 21 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05166850 (Evidence Based Targeted Water Sanitation, and Hygiene Interventions to Reduce Cholera in Hotspots in the Democratic Republic of the Congo), which is not on this map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05166850 narecruitingnot on this map

Evidence Based Targeted Water Sanitation, and Hygiene Interventions to Reduce Cholera in Hotspots in the Democratic Republic of the Congo

TypeinterventionalSponsorJohns Hopkins Bloomberg School of Public HealthRan2021 to 2026Enrolled2,900ConditionsCholera, Water-Related Diseases, Diarrhea InfectiousArmsPICHA7 mHealth program, Standard Arm
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Christine Marie GeorgeDepartment of International Health, Program of Global Disease Epidemiology and Control, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Presence SanvuraCenter for Tropical Diseases and Global Health, Université Catholique de Bukavu, Bukavu, Democratic Republic of the Congo.ORCID 0009-0007-8240-2562
Jean-Claude BisimwaCenter for Tropical Diseases and Global Health, Université Catholique de Bukavu, Bukavu, Democratic Republic of the Congo.ORCID 0009-0008-8906-7653
Kelly EndresDepartment of International Health, Program of Global Disease Epidemiology and Control, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.ORCID 0000-0003-3427-298X
Alves NamuneshaCenter for Tropical Diseases and Global Health, Université Catholique de Bukavu, Bukavu, Democratic Republic of the Congo.
Willy FelicienCenter for Tropical Diseases and Global Health, Université Catholique de Bukavu, Bukavu, Democratic Republic of the Congo.
Blessing Muderhwa BanywesizeCenter for Tropical Diseases and Global Health, Université Catholique de Bukavu, Bukavu, Democratic Republic of the Congo.ORCID 0009-0005-6459-0841
Camille WilliamsDepartment of International Health, Program of Global Disease Epidemiology and Control, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Jamie PerinDepartment of International Health, Program of Global Disease Epidemiology and Control, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.ORCID 0000-0002-5482-6620
David A SackDepartment of International Health, Program of Global Disease Epidemiology and Control, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.ORCID 0000-0002-9338-5119
Raissa BorotoCenter for Tropical Diseases and Global Health, Université Catholique de Bukavu, Bukavu, Democratic Republic of the Congo.
Gisèle NsimireCenter for Tropical Diseases and Global Health, Université Catholique de Bukavu, Bukavu, Democratic Republic of the Congo.
Feza RugushaCenter for Tropical Diseases and Global Health, Université Catholique de Bukavu, Bukavu, Democratic Republic of the Congo.
Freddy EndeleyaCenter for Tropical Diseases and Global Health, Université Catholique de Bukavu, Bukavu, Democratic Republic of the Congo.
Pacifique KitumainiCenter for Tropical Diseases and Global Health, Université Catholique de Bukavu, Bukavu, Democratic Republic of the Congo.
Claude LunyelunyeCenter for Tropical Diseases and Global Health, Université Catholique de Bukavu, Bukavu, Democratic Republic of the Congo.
Emmanuel BuhendwaCenter for Tropical Diseases and Global Health, Université Catholique de Bukavu, Bukavu, Democratic Republic of the Congo.
Pascal Kitumaini BujiririCenter for Tropical Diseases and Global Health, Université Catholique de Bukavu, Bukavu, Democratic Republic of the Congo.
Jessy TumusifuCenter for Tropical Diseases and Global Health, Université Catholique de Bukavu, Bukavu, Democratic Republic of the Congo.
Brigitte MunyerenkanaCenter for Tropical Diseases and Global Health, Université Catholique de Bukavu, Bukavu, Democratic Republic of the Congo.
Shubhanshi TrivediDivision of Infectious Diseases, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA.ORCID 0000-0001-6891-2290
Kilee L DavisDivision of Infectious Diseases, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA.ORCID 0009-0000-5198-9099
Kenadee JacobsonDivision of Infectious Diseases, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA.ORCID 0000-0003-2539-4395
Khaled M Al-DandashiDivision of Infectious Diseases, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA.ORCID 0009-0000-1810-5255
Daniel T LeungDivision of Infectious Diseases, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA.ORCID 0000-0001-8401-0801
Laura E CaulfieldDepartment of International Health, Program in Human Nutrition, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.ORCID 0000-0001-7152-1004
Justin BengehyaDepartment of International Health, Program in Human Nutrition, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Ghislain MahesheBureau de l'Information Sanitaire, Surveillance Epidémiologique et Recherche Scientifique, Division Provinciale de la Santé Sud Kivu, Ministère de la Santé, Bukavu, Democratic Republic of the Congo.ORCID 0000-0003-2227-5999
Cirhuza CikomolaCenter for Tropical Diseases and Global Health, Université Catholique de Bukavu, Bukavu, Democratic Republic of the Congo.
Alain MwishingoCenter for Tropical Diseases and Global Health, Université Catholique de Bukavu, Bukavu, Democratic Republic of the Congo.ORCID 0000-0002-8743-4295
Lucien BisimwaCenter for Tropical Diseases and Global Health, Université Catholique de Bukavu, Bukavu, Democratic Republic of the Congo.ORCID 0000-0001-5570-5807

Funding

A Ring Water, Sanitation, and Hygiene Intervention to Reduce Cholera in Hotspots in BangladeshR01AI148332 · NIAID · JOHNS HOPKINS UNIVERSITY · PI GEORGE, CHRISTINE MARIE · 2020 to 2025
$3.2M
Dr Thomas D. Rees and Natalie B. Rees Presidential Endowed Chair in Global MedicineForeign and Commonwealth Development Office 215674Z19ZJohns Hopkins School of Public HealthNIAID NIH HHS R01 AI148332NIH HHS 1R01AI148332-01Reckitt Global Hygiene InstituteWellcomeWellcome Trust
6 · The paper itself

Abstract

backgroundWe assessed whether the Preventative Intervention for Cholera for 7 Days (PICHA7) WASHmobile program reduced diarrhea and cholera serological responses and improved child growth in the Democratic Republic of the Congo (DRC).

methodsThe PICHA7 WASHmobile cluster-randomized controlled trial enrolled diarrhea patient households in urban Bukavu, DRC. Households were randomized into 2 arms: single in-person visit for the DRC government's diarrhea patient standard message on oral rehydration solution use and a basic water, sanitation, and hygiene (WASH) message (standard arm); or this standard message and the PICHA7 program with weekly voice and text mobile health (mHealth) messages and quarterly in-person visits (PICHA7 arm). The primary outcome was diarrhea in the past 2 weeks assessed monthly for 12 months. Secondary outcomes were healthcare facility visits for diarrhea, Vibrio cholerae serological response, stunting, underweight, wasting, and diarrhea with rice water stool over 12 months. A Vibrio cholerae serological response was defined by a rise in serum V. cholerae O1 O-specific polysaccharide (OSP) immunoglobulin A (IgA) or immunoglobulin G (IgG) from baseline to the 1-month follow-up. Generalized estimating equations were used for regression models to account for clustering at the individual and household level.

resultsBetween December 2021 and December 2022, 2334 participants were randomly allocated to 2 arms: 1138 standard arm and 1196 PICHA7 arm. Diarrhea prevalence during the 12-month surveillance period was significantly lower among PICHA7 arm participants compared to standard arm participants (prevalence ratio, 0.39 [95% confidence interval {CI}: .32-.48]). PICHA7 arm participants had lower odds of visiting a healthcare facility for diarrhea during the 12-month surveillance period (OR: 0.44 [95% CI: .25-.77]) and lower odds of diarrhea with rice water stool (OR: 0.48 [95% CI: .27-.86]). Significantly lower V. cholerae IgA serological responses were observed in the PICHA7 arm compared to the standard arm, defined by a change in serum IgA to V. cholerae O1 OSP from baseline to the 1-month follow-up (coefficient of between-arm difference from baseline to 1 month: -0.85 [95% CI: -1.60 to -.09]). PICHA7 arm children aged <5 years were significantly less likely to be stunted (52% vs 63% standard arm) (OR: 0.65 [95% CI: .43-.99]) at the 12-month follow-up. All WASH components had high adherence.

conclusionsThe PICHA7 WASHmobile program, which combines mHealth with quarterly in-person visits, lowered healthcare facility visits for diarrhea, cholera serological responses, and stunting in the DRC. CLINICAL TRIALS REGISTRATION: NCT05166850.

Indexed as

CholeraDiarrheaHygieneSanitationAdultChildChild, PreschoolDemocratic Republic of the CongoFemaleHumansInfantMaleTelemedicinecholeradiarrheamobile healthrandomized controlled trialserosurveillance

Identifiers

PMID41206550
PMCPMC12596403

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.